Clinical trials
Uterine Cervical Neoplasms trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
58 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 6 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 5 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 5 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Unknown status | 16 |
| Recruiting | 14 |
| Active, not recruiting | 3 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tata Memorial Hospital | 24 |
| International Agency for Research on Cancer | 3 |
| All India Institute of Medical Sciences | 2 |
| GlaxoSmithKline | 2 |
| International Atomic Energy Agency | 2 |
| University College, London | 2 |
| AIDS Malignancy Consortium | 1 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Banaras Hindu University | 1 |
| CHA University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Cervical Neoplasms | 58 |
| Neoplasms | 5 |
| Papillomavirus Infections | 5 |
| Recurrence | 5 |
| Breast Neoplasms | 4 |
| Endometrial Neoplasms | 4 |
| Acquired Immunodeficiency Syndrome | 3 |
| Uterine Cervical Dysplasia | 3 |
| Mouth Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
Trials
Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.